LV

LifeSci Venture Partners

North America, New York, United States, New York

Description

LifeSci Venture Partners is an early-stage investment firm that invests in early-stage life sciences and healthcare companies.

Investor Profile

LifeSci Venture Partners has made 37 investments, with 2 in the past 12 months and 5% as lead.

Stage Focus

  • Series B (41%)
  • Series A (24%)
  • Series C (22%)
  • Post Ipo Equity (5%)
  • Series Unknown (3%)
  • Series D (3%)
  • Series E (3%)

Country Focus

  • United States (95%)
  • Israel (5%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Pharmaceutical
  • Medical
  • Medical Device
  • Biopharma
  • Oncology
  • Clinical Trials
  • Life Science
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does LifeSci Venture Partners frequently co-invest with?

venBio Partners
North America, California, United States, San Francisco
Co-Investments: 6
CA
North America, Massachusetts, United States, Boston
Co-Investments: 8
Samsara BioCapital
North America, California, United States, Palo Alto
Co-Investments: 8
Venrock Healthcare Capital Partners
North America, California, United States, Palo Alto
Co-Investments: 8
RTW Investments
North America, New York, United States, New York
Co-Investments: 7
Perceptive Advisors
North America, New York, United States, New York
Co-Investments: 7
Redmile Group
North America, California, United States, San Francisco
Co-Investments: 7
Logos Capital
North America, California, United States, San Francisco
Co-Investments: 8
Janus Henderson Investors
Europe, England, United Kingdom, London
Co-Investments: 8
Invus
North America, New York, United States, New York
Co-Investments: 6

Which angels does LifeSci Venture Partners often collaborate with?

SK
North America, California, United States, Los Angeles
Shared Deals: 1
JR
North America, California, United States, San Francisco
Shared Deals: 1
RK
North America, California, United States, Los Angeles
Shared Deals: 1

What are some of recent deals done by LifeSci Venture Partners?

Candid Therapeutics

San Diego, California, United States

Candid Therapeutics is a biotechnology company that focuses on the treatment of a range of immunological conditions.

BiotechnologyProduct ResearchTherapeutics
Series ASep 9, 2024
Amount Raised: $370,000,000
Averto Medical

Belmont, California, United States

Averto Medical is a medical device manufacturing company.

Health CareManufacturingMedical Device
Series AMay 7, 2024
Amount Raised: $30,000,000
ProfoundBio

Seattle, Washington, United States

ProfoundBio is a developer of targeted therapeutics intended for patients with cancer.

BiotechnologyOncologyTherapeutics
Series BFeb 13, 2024
Amount Raised: $112,000,000
Beta Bionics

Irvine, California, United States

Beta Bionics is a biotechnology company that develops an integrated bionic pancreas system called the iLet.

BiotechnologyDiabetesMedical Device
Series DAug 30, 2023
Amount Raised: $100,000,000
MOMA Therapeutics

Cambridge, Massachusetts, United States

MOMA Therapeutics operates as a biotechnology company.

BiotechnologyMedicalTherapeutics
Series BMay 10, 2022
Amount Raised: $150,000,000
Beta Bionics

Irvine, California, United States

Beta Bionics is a biotechnology company that develops an integrated bionic pancreas system called the iLet.

BiotechnologyDiabetesMedical Device
Series CFeb 17, 2022
Amount Raised: $57,000,000
Ceptur Therapeutics

Hillsborough, New Jersey, United States

Revolutionizing gene silencing by developing targeted oligonucleotide therapeutics based on U1 Adaptor technology

BiotechnologyMedicalTherapeutics
Series AJan 19, 2022
Amount Raised: $75,000,000
Antios Therapeutics

Atlanta, Georgia, United States

Antios Therapeutics is a biopharmaceutical company developing innovative therapies for viral diseases.

BiopharmaBiotechnologyTherapeutics
Series BNov 3, 2021
Amount Raised: $75,000,000
Clade Therapeutics

Cambridge, Massachusetts, United States

Clade Therapeutics discovers and delivers next-generation cell medicines to improve the lives of patients.

BiotechnologyHealth CareMedical
Series ANov 3, 2021
Amount Raised: $87,000,000
Science 37

Culver City, California, United States

Science 37 is a clinical research company that facilitates universal participation in clinical trials for patients and providers.

BiotechnologyClinical TrialsHealth CareHome Health Care
Post Ipo EquityOct 7, 2021
Amount Raised: $200,000,000